2020
DOI: 10.1016/j.crad.2019.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Contrast medium injection protocols for coronary CT angiography: should contrast medium volumes be tailored to body weight or body surface area?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Metoprolol was used to control the heart rate and heartbeat rhythm in patients with AF. The nonionic contrast agent iohexol (350 mgI/mL, 0.8 mL/kg) was injected venously using a double-barrel high-pressure syringe with a scan range from 0.5 cm below the tracheal bifurcation to the palpebral surface of the heart, which used the bolus tracking technique ( 11 , 12 ). Using the retrospective ECG gating technology, the scanning parameters were as follows: tube voltage 80–120 kV, tube current 280–350 mAs/rev, collimation 128×0.625, pitch 0.18, matrix 512×512, rotation time 330 ms, and scanning field of view (FOV) 250 mm, with adjustment of the scan voltage and current according to the patient’s body mass index (BMI) to reduce scanning dose.…”
Section: Methodsmentioning
confidence: 99%
“…Metoprolol was used to control the heart rate and heartbeat rhythm in patients with AF. The nonionic contrast agent iohexol (350 mgI/mL, 0.8 mL/kg) was injected venously using a double-barrel high-pressure syringe with a scan range from 0.5 cm below the tracheal bifurcation to the palpebral surface of the heart, which used the bolus tracking technique ( 11 , 12 ). Using the retrospective ECG gating technology, the scanning parameters were as follows: tube voltage 80–120 kV, tube current 280–350 mAs/rev, collimation 128×0.625, pitch 0.18, matrix 512×512, rotation time 330 ms, and scanning field of view (FOV) 250 mm, with adjustment of the scan voltage and current according to the patient’s body mass index (BMI) to reduce scanning dose.…”
Section: Methodsmentioning
confidence: 99%
“…Martin et al [ 23 ] evaluated the feasibility of a vendor’s software using a tube voltage-tailored CM application, which still resulted in more than 25% of the CTAs with attenuations in the ascending aorta below 400 HU. In another study with bolus tracking, Yin et al [ 24 ] evaluated protocols tailored for BMI or BSA, and, either way, cases of insufficient attenuation in the aorta occurred. The use of AI, as presented in the current study, could potentially improve different protocols by automatically detecting cases with insufficient attenuation when using a test bolus protocol.…”
Section: Discussionmentioning
confidence: 99%